Effects of Substitution on 9-(3-Bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopentabnaphthalene-1,8-dione, a Dihydropyridine ATP-Sensitive Potassium Channel Opener

Autor: J. Altenbach, Robert, E. Brune, Michael, A. Buckner, Steven, J. Coghlan, Michael, V. Daza, Anthony, Fabiyi, Adebola, Gopalakrishnan, Murali, F. Henry, Rodger, Khilevich, Albert, E. Kort, Michael, Milicic, Ivan, E. Scott, Victoria, C. Smith, Jamie, L. Whiteaker, Kristi, A. Carroll, William

Publikováno v: Journal of Medicinal Chemistry; November 2006, Vol. 49 Issue: 23 p6869-6887, 19p

2,4-Diaminopyrimidine Derivatives as Potent Growth Hormone Secretagogue Receptor Antagonists

Autor: D. Serby, Michael, Zhao, Hongyu, G. Szczepankiewicz, Bruce, Kosogof, Christi, Xin, Zhili, Liu, Bo, Liu, Mei, T. J. Nelson, Lissa, Kaszubska, Wiweka, Douglas Falls, H., Schaefer, Verlyn, N. Bush, Eugene, Shapiro, Robin, A. Droz, Brian, E. Knourek-Segel, Victoria, A. Fey, Thomas, E. Brune, Michael, W. A. Beno, David, M. Turner, Theresa, A. Collins, Christine, B. Jacobson, Peer, L. Sham, Hing, Liu, Gang

Publikováno v: Journal of Medicinal Chemistry; April 2006, Vol. 49 Issue: 8 p2568-2578, 11p

Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor antagonists.

Autor: G, Witte David, E, Brune Michael, P, Katwala Sweta, Ivan, Milicic, Deanne, Stolarik, Yu-Hua, Hui, C, Marsh Kennan, F, Kerwin James, D, Meyer Michael, A, Hancock Arthur

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; February 2002, Vol. 300 Issue: 2 p495-504, 10p

Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.

Autor: E, Brune Michael, P, Katwala Sweta, Ivan, Milicic, G, Witte David, F, Kerwin James, D, Meyer Michael, A, Hancock Arthur, Michael, Williams

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; February 2002, Vol. 300 Issue: 2 p487-94, 8p